Health expert Jennifer Caudle joins Rite Aid in promoting flu shot availability
In an effort to encourage people to get a flu shot this season, Camp Hill, Pa.-based Rite Aid is teaming with Dr. Jennifer Caudle, a nationally renowned health expert and practicing family physician, during National Influenza Vaccination Week.
“Vaccination is the single best way to protect yourself against the flu,” Caudle said. “Rite Aid pharmacists undergo special training and are professionally certified to administer immunizations, and with thousands of locations across the country, Rite Aid pharmacies are a convenient and professional setting for flu shots. That’s why I’m partnering with Rite Aid and reminding people to get vaccinated as soon as possible.”
Caudle and Rite Aid certified immunizing pharmacist Chris Altman will host a special flu-focused Facebook Live event on Dec. 6 at 8 p.m. ET to answer questions about the flu, address common misconceptions and provide helpful tips on how to stay healthy throughout flu season.
“Our pharmacists are on the frontlines of healthcare in the communities they serve, and when it comes to fighting the flu, as certified immunizers, they can be a patient’s first line of defense,” stated Jocelyn Konrad, Rite Aid executive vice president of pharmacy. “And because flu activity typically peaks between December and March according to the CDC, National Influenza Vaccination Week is the perfect time to remind people there’s still time to get vaccinated and protect themselves as well as their family this flu season.”
Seasonal flu shots are available at Rite Aid locations across the country. This year, Rite Aid is offering three types of flu vaccines: a quadrivalent flu vaccine which offers protection against four strains of the flu; the standard trivalent vaccine; and FLUAD, a trivalent vaccine with adjuvant, an ingredient that helps create a stronger immune response to vaccination, which is approved for people 65 years old and older.
Amneal launches Clolar generic
Amneal’s biosciences arm recently introduced its generic of Clolar (clofarabine, 1mg/ml). The Bridgewater, N.J.-based company will be shipping the product in a single-dose vial containing 20 mg of the active ingredient in 20 ml of clear sterile solution.
“We are pleased to expand our product portfolio with clofarabine,” Amneal Biosciences president Charles Lucarelli said. “It’s an important addition to our growing oncology line.”
The product had $53 million in sales for the 12 months ended September 2017, according to data from IQVIA.
FDA approves Breckenridge’s Megace ES generic
The Food and Drug Administration has approved Breckenridge Pharmaceuticals’ generic of Megace ES (megestrol acetate oral suspension).
The drug is a concentrated suspension that is indicated to treat loss of appetite, severe malnutrition or unexplained significant weight loss in patients with AIDS. The drug had generic and brand sales of $17.6 million for the 12 months ended October 2017, according to IQVIA data.
The Boca Raton, Fla.-based company said the product was launching immediately, having resolved litigation between it, Par Pharmaceuticals and Alkermes Pharma Ireland.